Qube Research & Technologies (QRT)’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-79,038
Closed -$2.49M 3955
2024
Q4
$2.49M Buy
79,038
+73,840
+1,421% +$3.51M ﹤0.01% 1790
2024
Q3
$301K Buy
+5,198
New +$255K ﹤0.01% 2425
2022
Q4
Sell
-22,803
Closed -$889K 3077
2022
Q3
$889K Buy
+22,803
New +$1.04M 0.01% 1246

Other funds holding ASTH

Qube Research & Technologies (QRT)'s ASTH Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Astrana Health (ASTH) in Q1 2025, closing a stake of 79,038 shares — an estimated $2.49M sold.

Qube Research & Technologies (QRT) first reported a position in ASTH in Q3 2022 and held it in 3 quarters. The position peaked at $2.49M in Q4 2024. 168 funds tracked by Wall St. Rank hold ASTH as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Astrana Health position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 79,038 Astrana Health shares in Q1 2025, an estimated $2.49M.
  • Qube Research & Technologies (QRT) first reported a position in Astrana Health in Q3 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Astrana Health position peaked at $2.49M in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Astrana Health as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.